Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting No phase listed Observational

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

ClinicalTrials.gov ID: NCT05589714

Public ClinicalTrials.gov record NCT05589714. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:09 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an international, multicenter study with two components: Registry * A standardized genetic screening and a prospective, standardized, cross-sectional clinical data collection * Enrollment is open to all genes on the RD Rare Gene List Natural History Study * A prospective, standardized, longitudinal Natural History Study * Enrollment opens gene-by-gene, based on funding and within-gene Registry enrollment The study objectives are as follows. Registry Objectives 1. Genotype Characterization 2. Cross-Sectional Phenotype Characterization (within gene) 3. Establish a Link to My Retina Tracker Registry (MRTR) 4. Ancillary Exploratory Studies - Pooling of Genes Natural History Study Objectives 1. Natural History (within gene) 2. Structure-Function Relationship (within gene) 3. Risk Factors for Progression (within gene) 4. Ancillary Exploratory Studies - Pooling of Genes

Study identification

NCT ID
NCT05589714
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Enrollment
1,500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 11, 2023 (Actual)
Primary completion
Dec 15, 2029 (Estimated)
Completion
Dec 15, 2030 (Estimated)
Last update posted
Oct 29, 2026

2023 – 2030

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
University of Arkansas, Jones Eye Institute Little Rock Arkansas 72205 Recruiting
USC Roski Eye Institute Los Angeles California 90033 Recruiting
University of California San Francisco San Francisco California 94158 Recruiting
University of Florida Health Jacksonville Jacksonville Florida 32209 Recruiting
University of Miami, Bascom Palmer Eye Institute Miami Florida 33136 Recruiting
Emory University, Emory Eye Center Atlanta Georgia 30322 Recruiting
Johns Hopkins University, Wilmer Eye Institute Baltimore Maryland 21236 Recruiting
Harvard Univ., Massachusetts Eye and Ear Infirmary Boston Massachusetts 02114 Recruiting
University of Michigan, Kellogg Eye Center Ann Arbor Michigan 48105 Recruiting
Mayo Clinic Rochester Minnesota 55905 Recruiting
Duke University, Duke Eye Center Durham North Carolina 27705 Recruiting
Oregon Health & Science Univ., Casey Eye Institute Portland Oregon 97239 Recruiting
University of Pennsylvania, Scheie Eye Institute Philadelphia Pennsylvania 19104 Recruiting
UPMC Eye Center Pittsburgh Pennsylvania 15213 Recruiting
Retina Foundation of the Southwest Dallas Texas 75231 Recruiting
Baylor College of Medicine, Alkek Eye Center Houston Texas 77030 Recruiting
University of Utah, John Moran Eye Center Salt Lake City Utah 84132 Recruiting
University of Wisconsin Madison Madison Wisconsin 53711 Recruiting
Medical College of Wisconsin Eye Institute Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05589714, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2026 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05589714 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →